Asociación entre la hidradenitis supurativa y el síndrome metabólico

Revisión sistemática y metaanálisis

Translated title of the contribution: Association Between Hidradenitis Suppurativa and Metabolic Syndrome: A Systematic Review and Meta-analysis

M. J.M. Rodríguez-Zuñiga, H. A. García-Perdomo, Alex Ortega Loayza

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Recent studies have shown a relationship between hidradenitis suppurativa (HS) and metabolic syndrome (MS), but the literature offers no meta-analysis restricted to studies that have been adjusted for confounders. Objective: To determine the association between HS and MS. Methods: A systematic review and meta-analysis of observational studies on HS and MS in adults. We searched MEDLINE, SCOPUS, SCIELO, Google Scholar, Science Direct, and LILACS from the inception of the databases to January 2016. We performed a random effects model meta-analysis for studies reporting adjusted and crude odds ratios (ORs) with 95% CIs. A subgroup analysis was related to the type of HS patient (general patients vs hospital patients) and age group (adults vs children and adults). Results: Five studies including 3950 HS patients were analyzed. We found that MS was pres-ent in 9.64% of HS patients (OR, 1.82; 95%, CI 1.39–2.25). Studies from tertiary care hospital dermatology clinics (OR, 2.82; 95% CI, 0.58–5.06) reported a greater risk for MS than studies carried out in patients treated outside hospitals (OR, 1.78; 95% CI, 1.34–2.22). Studies that included pediatric populations reported a significant association (OR, 2.10; 95% CI, 1.58–2.62). Limitation: Few of the included studies reported adjusted ORs. Conclusions: HS patients have an increased risk for MS. Clinicians should consider screening HS patients for metabolic risk factors.

Original languageSpanish
Pages (from-to)279-288
Number of pages10
JournalActas Dermo-Sifiliograficas
Volume110
Issue number4
DOIs
StatePublished - May 1 2019

Fingerprint

Hidradenitis Suppurativa
Meta-Analysis
Odds Ratio
Tertiary Healthcare
Dermatology
Tertiary Care Centers
MEDLINE
Observational Studies
Age Groups
Databases
Pediatrics

Keywords

  • Cardiovascular disease
  • Epidemiology
  • Hidradenitis suppurativa
  • Meta-analisis
  • Metabolic syndrome
  • Psoriasis
  • Systematic review

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Histology
  • Dermatology

Cite this

Asociación entre la hidradenitis supurativa y el síndrome metabólico : Revisión sistemática y metaanálisis. / Rodríguez-Zuñiga, M. J.M.; García-Perdomo, H. A.; Ortega Loayza, Alex.

In: Actas Dermo-Sifiliograficas, Vol. 110, No. 4, 01.05.2019, p. 279-288.

Research output: Contribution to journalArticle

@article{e661038a433749eba7f2acdd6f5b015b,
title = "Asociaci{\'o}n entre la hidradenitis supurativa y el s{\'i}ndrome metab{\'o}lico: Revisi{\'o}n sistem{\'a}tica y metaan{\'a}lisis",
abstract = "Background: Recent studies have shown a relationship between hidradenitis suppurativa (HS) and metabolic syndrome (MS), but the literature offers no meta-analysis restricted to studies that have been adjusted for confounders. Objective: To determine the association between HS and MS. Methods: A systematic review and meta-analysis of observational studies on HS and MS in adults. We searched MEDLINE, SCOPUS, SCIELO, Google Scholar, Science Direct, and LILACS from the inception of the databases to January 2016. We performed a random effects model meta-analysis for studies reporting adjusted and crude odds ratios (ORs) with 95{\%} CIs. A subgroup analysis was related to the type of HS patient (general patients vs hospital patients) and age group (adults vs children and adults). Results: Five studies including 3950 HS patients were analyzed. We found that MS was pres-ent in 9.64{\%} of HS patients (OR, 1.82; 95{\%}, CI 1.39–2.25). Studies from tertiary care hospital dermatology clinics (OR, 2.82; 95{\%} CI, 0.58–5.06) reported a greater risk for MS than studies carried out in patients treated outside hospitals (OR, 1.78; 95{\%} CI, 1.34–2.22). Studies that included pediatric populations reported a significant association (OR, 2.10; 95{\%} CI, 1.58–2.62). Limitation: Few of the included studies reported adjusted ORs. Conclusions: HS patients have an increased risk for MS. Clinicians should consider screening HS patients for metabolic risk factors.",
keywords = "Cardiovascular disease, Epidemiology, Hidradenitis suppurativa, Meta-analisis, Metabolic syndrome, Psoriasis, Systematic review",
author = "Rodr{\'i}guez-Zu{\~n}iga, {M. J.M.} and Garc{\'i}a-Perdomo, {H. A.} and {Ortega Loayza}, Alex",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.ad.2018.10.020",
language = "Spanish",
volume = "110",
pages = "279--288",
journal = "Actas Dermo-Sifiliograficas",
issn = "0001-7310",
publisher = "Ediciones Doyma, S.L.",
number = "4",

}

TY - JOUR

T1 - Asociación entre la hidradenitis supurativa y el síndrome metabólico

T2 - Revisión sistemática y metaanálisis

AU - Rodríguez-Zuñiga, M. J.M.

AU - García-Perdomo, H. A.

AU - Ortega Loayza, Alex

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Background: Recent studies have shown a relationship between hidradenitis suppurativa (HS) and metabolic syndrome (MS), but the literature offers no meta-analysis restricted to studies that have been adjusted for confounders. Objective: To determine the association between HS and MS. Methods: A systematic review and meta-analysis of observational studies on HS and MS in adults. We searched MEDLINE, SCOPUS, SCIELO, Google Scholar, Science Direct, and LILACS from the inception of the databases to January 2016. We performed a random effects model meta-analysis for studies reporting adjusted and crude odds ratios (ORs) with 95% CIs. A subgroup analysis was related to the type of HS patient (general patients vs hospital patients) and age group (adults vs children and adults). Results: Five studies including 3950 HS patients were analyzed. We found that MS was pres-ent in 9.64% of HS patients (OR, 1.82; 95%, CI 1.39–2.25). Studies from tertiary care hospital dermatology clinics (OR, 2.82; 95% CI, 0.58–5.06) reported a greater risk for MS than studies carried out in patients treated outside hospitals (OR, 1.78; 95% CI, 1.34–2.22). Studies that included pediatric populations reported a significant association (OR, 2.10; 95% CI, 1.58–2.62). Limitation: Few of the included studies reported adjusted ORs. Conclusions: HS patients have an increased risk for MS. Clinicians should consider screening HS patients for metabolic risk factors.

AB - Background: Recent studies have shown a relationship between hidradenitis suppurativa (HS) and metabolic syndrome (MS), but the literature offers no meta-analysis restricted to studies that have been adjusted for confounders. Objective: To determine the association between HS and MS. Methods: A systematic review and meta-analysis of observational studies on HS and MS in adults. We searched MEDLINE, SCOPUS, SCIELO, Google Scholar, Science Direct, and LILACS from the inception of the databases to January 2016. We performed a random effects model meta-analysis for studies reporting adjusted and crude odds ratios (ORs) with 95% CIs. A subgroup analysis was related to the type of HS patient (general patients vs hospital patients) and age group (adults vs children and adults). Results: Five studies including 3950 HS patients were analyzed. We found that MS was pres-ent in 9.64% of HS patients (OR, 1.82; 95%, CI 1.39–2.25). Studies from tertiary care hospital dermatology clinics (OR, 2.82; 95% CI, 0.58–5.06) reported a greater risk for MS than studies carried out in patients treated outside hospitals (OR, 1.78; 95% CI, 1.34–2.22). Studies that included pediatric populations reported a significant association (OR, 2.10; 95% CI, 1.58–2.62). Limitation: Few of the included studies reported adjusted ORs. Conclusions: HS patients have an increased risk for MS. Clinicians should consider screening HS patients for metabolic risk factors.

KW - Cardiovascular disease

KW - Epidemiology

KW - Hidradenitis suppurativa

KW - Meta-analisis

KW - Metabolic syndrome

KW - Psoriasis

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=85064736069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064736069&partnerID=8YFLogxK

U2 - 10.1016/j.ad.2018.10.020

DO - 10.1016/j.ad.2018.10.020

M3 - Article

VL - 110

SP - 279

EP - 288

JO - Actas Dermo-Sifiliograficas

JF - Actas Dermo-Sifiliograficas

SN - 0001-7310

IS - 4

ER -